novo glp-1 drug Novo's Wegovy becomes first approved for MASH GLP-1s for Alzheimer's: Novo Nordisk
Description
0.3 kg with placebo [25]
Pills like metformin, Qsymia, Contrave, and Xenical offer non-injectable alternatives with different mechanisms of action
Biomolecules 15 , 46 (2025)
doi:10.3389/fcimb.2022.978643 118
